1717 Main St, Ste 3388, Dallas, TX 75201, USA
Vaxxinity is incorporated in Delaware.
Vaxxinity was founded in 2021.
Vaxxinity’s shares are traded on the Nasdaq Global Market under the symbol “VAXX”.
Vaxxinity’s initial public offering (IPO) occurred on November 11, 2021.
Vaxxinity’s fiscal year ends on December 31.
Shares of Vaxxinity’s stock can be purchased by contacting a securities broker of your choice.
Vaxxinity does not currently pay dividends or offer a stock reinvestment plan.
Vaxxinity’s transfer agent is American Stock Transfer (AST).
For questions about your stock please contact our transfer agent, American Stock Transfer (AST).
Quarterly & Annual reports and other investor materials are available in the “Investors” section of Vaxxinity’s corporate website. Additionally, all SEC filings can also be accessed directly from the SEC at www.sec.gov.
Please click here to be directed to the email alerts page.
For investor inquiries, please send an email to IR@vaxxinity.com